ArticleBMJ open2024

Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocol.

He Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.